NorthView Acquisition Corporation (NVAC)

NASDAQ: NVAC · IEX Real-Time Price · USD
NorthView Acquisition currently trades with the ticker symbol NVACU
10.05 -0.06 (-0.57%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap222.36M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out22.13M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume121,655
Open10.08
Previous Close10.11
Day's Range10.05 - 10.11
52-Week Range10.00 - 10.12
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About NVAC

NorthView Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search on businesses that are focused on healthcare innovation. We anticipate targeting what are traditionally known as “small cap” companies domiciled in North America, Europe and/or the Asia Pacific regions that are developing assets in the biopharmaceutical, medic...

IndustryBlank Check / SPAC
IPO DateDec 21, 2021
CEOJack Stover
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolNVAC
Full Company Profile

News

NorthView Acquisition Corp. Announces Pricing of Upsized $165,000,000 Initial Public Offering

NorthView Acquisition Corp. (NASDAQ: NVACU) announced today that it priced its initial public offering of 16,500,000 units at a price to the public of $10.00 per unit.

1 month ago - GLOBE NEWSWIRE

NorthView Acquisition IPO Registration Document (S-1)

NorthView Acquisition has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

SPAC NorthView Acquisition files for a $180 million IPO, targeting small cap healthcare

NorthView Acquisition, a blank check company targeting small cap healthcare businesses in North America, Europe, and APAC, filed on Thursday with the SEC to raise up to $180 million.

7 months ago - Renaissance Capital